 ROCKVILLE, Md., Nov. 18, 2020 GLOBE NEWSWIRE -- Supernus Pharmaceuticals, Inc. Nasdaq: SUPN, a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system CNS diseases, today announced that the Companys management will participate in a fireside chat as part of the Piper Sandler 32nd Annual Virtual Healthcare Conference, being held December 1-3, 2020. The Company will also host investor meetings on Thursday, December 3, 2020. 